GlassScriptPhysician profile
Stephanie Hunt
NPI 1396148920
$2,830.53
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $932 · 2022: $646 · 2023: $619 · 2024: $224 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $826.71 | 2021-2025 | Xeomin |
| Bayer Healthcare Pharmaceuticals INC. | $443.11 | 2021-2023 | |
| Novo Nordisk INC | $325.99 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $262.19 | 2021-2024 | |
| Allergan, INC. | $215.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $158.13 | 2021 | |
| Amgen INC. | $137.39 | 2025 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.27 | 2022 | |
| Lilly USA, LLC | $55.64 | 2021-2023 | Mounjaro, Trulicity |
| Corium, LLC | $52.79 | 2021 | |
| Medline Industries LP | $43.29 | 2024 | Medline |
| Exact Sciences Corporation | $41.25 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $36.27 | 2023 | Quviviq |
| Biogen, INC. | $33.74 | 2021 | |
| Currax Pharmaceuticals LLC | $30.18 | 2023-2025 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $23.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.